Skip to main content
. 2023 Oct 9;12(11):e230328. doi: 10.1530/EC-23-0328

Table 2.

Clinical presentation and outcome of 9 PitNETs expressing PIT1 and SF1.

Case Presentation Maximum tumour diameter (mm) Cavernous sinus or sphenoid sinus invasion Status after surgery Follow-up duration (months) Treatment with SRL Recurrence or progression
1 Acromegaly 19 No Cure 48 No
2 Acromegaly, amenorrhoea 28 Yes Residual macrotumour
3 Acromegaly 12 No Biochemical persistence 129 Yes No
4 Acromegaly, amenorrhoea 38 No Residual macrotumour 132 Yes No
5 Visual field deficit 32 Yes Residual macrotumour 34 No No
6 Acromegaly 15 No Cure 50 No
7 Acromegaly 24 No Cure 59 No
8 Acromegaly 12 No Cure 36 No
9 Acromegaly 8 No Cure 12 No